Glucotrack, Inc. [GCTK] - appoints Erik Emerson as CEO

Effective July 15, 2026, Erik Emerson, a 25-year veteran of the biopharmaceutical industry and former CEO of Apimeds Pharmaceuticals, has been appointed as the Chief Executive Officer of Glucotrack, Inc.

View source filing ↗